Enoblituzumab
Enoblituzumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Enoblituzumab is under investigation in clinical trial NCT02982941 (Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors).
| Trade Name | Enoblituzumab |
| Generic | Enoblituzumab |
| Enoblituzumab Other Names | Enoblituzumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Enoblituzumab
